El valor renacido del Ibex que gusta a todos los expertos para seguir subiendo

The Ibex index, favored by experts, has shown renewed value this year, climbing by more than 22%. This performance is attributed to the unanimous support from investment firms invested in its stock, who anticipate further gains in the medium term. Despite the Ibex struggling to stay above 19,100 points amidst doubts over debt, inflation, and the European Central Bank's rate hikes, the worst performer of the Ibex last year has resurged this year and is now showing positive momentum.

After falling by 16.62% in 2025, this year it is up by 22.4% and is the sixth highest performer among Spanish stocks. Puig, a perfume and fashion group, is particularly notable for its support from 19 investment firms, 13 of which recommend buying its stock. The group made its debut on the Spanish stock exchange on May 3, 2024, and has been trading at 24.40 euros since.

The company's shares have fallen by 25% since then. Experts are puzzled by the company's penalties, believing the uncertainties surrounding Trump's tariffs and economic doubts have unfairly penalized the company. The perfume, cosmetic, and skincare company attributes the decline to extraordinary costs associated with transactions in the first half of the year and unusual income booked in the first half of 2025.

Net profit, excluding double impacts, rose by 5.2% to 260 million euros, according to the group led by Marc Puig. The company's net sales, for brands such as Carolina Herrera, Jean Paul Gaultier, or Rabanne, increased by 2.4% to 2.354 million euros, with a constant currency and accounting period, the sales growth was 4.4%. Puig plans to release its third-quarter sales figures on October 21, and its Capital Markets Day is scheduled for October 28.

The company recently announced a decision that could boost its business in the medium term. The Catalan cosmetic and perfume company reached an agreement with the Química-Farmacéutica Corporativa Esteve to buy 50% of dermatological firm Isdin, which produces sunscreens, lotions, and skin treatments. With this deal, Puig will own 100% of Isdin's shares, integrating it into its dermatological product portfolio, which includes brands such as Uriage, and also owns smaller brands like Apivita, Kama Ayurveda, Loto del Sur, and Dr. Barbara Sturm.

The beauty brand of Puig also has a skincare line. The deal, priced at 1.200 million euros, is positive for Puig, according to analysts. Bankinter notes that with this acquisition, the company reinforces its exposure in the skincare area, representing 12% of the group's sales, with greater growth potential and margins, expanding beyond the primary perfume business (75% of sales) and fitting with the group's strategy to position itself in premium brands with high added value.

Technical analyst Jos� María Rodríguez of EXPANSIÓN believes the company's stocks convey positive signals after weathering recent turbulence in the market. However, the key lies in the strong resistance at the April and summer highs of 18.40-18.65 euros. This range of prices includes numerous resistances. Above these, a clear and promising signal of strength would be activated.

Beforehand, the potential movement towards the 20.50 euros area is expected. The top of the potential short-term uptrend channel serves as a warning.